Venus Concept Announces Second Quarter 2025 Financial Results
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the ...
What risk factors (e.g., regulatory, supply chain, litigation) were highlighted in the filing, and how might they affect the stock’s risk profile?
Are there any notable changes in the competitive landscape (e.g., competitor earnings, market share shifts) that could impact Venus Concept’s market position?
How does the company's valuation (P/E, EV/EBITDA, price/earnings growth) compare to other medical aesthetic technology companies?
27 days ago